✦ LIBER ✦

442 Fulvestrant (‘Faslodex’) demonstrates clinical benefit in heavily pre-treated patients with metastatic breast cancer

✍ Scribed by G.G. Steger; R. Barisch; C. Wenzel; D. Hussian; U. Plusching; R.M. Mader; C.C. Zielinski

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fulvestrant (‘Faslodex’) in pre-treated

✍ G.G. Steger; R. Bartsch; C. Wenzel; U. Pluschnig; D. Hussian; U. Sevelda; G.J. L 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Fulvestrant (‘Faslodex’) in heavily pret

✍ Brigitte Mlineritsch; Oskar Psenak; Peter Mayer; Martin Moik; Konrad Namberger; 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 300 KB

PO68 TREATMENT WITH ERIBULIN (HALAVEN) I

✍ Lynge, M.; Liposits, G.I.; Linnet, S.; Langkjer, S.T. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 52 KB

5062 Fulvestrant in heavily pre-treated

✍ R. Ratti; Z. Coccorullo; D. Guarneri; G. Addamo; G. Colloca; A. Venturino; E. Ca 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Fulvestrant in heavily pre-treated patie

✍ Chiara Catania; Gilda Ascione; Laura Adamoli; Tommaso De Pas; Marta Medici; Luci 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 173 KB

Trastuzumab and gemcitabine as salvage t

✍ Rupert Bartsch; Catharina Wenzel; Simon P. Gampenrieder; Ursula Pluschnig; Gabri 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 322 KB